Holen Sie sich die Stockscreener-App
9.19
3.37%
-0.29
Vir Biotechnology Inc Aktie (VIR) Neueste Nachrichten
Vir Biotechnology Stock Pre-Market (+0.2%): Ahead of Leerink Conference Presentation - Trefis
Biggest stock movers Tuesday: HIMS, VIR, CLVT, and more - MSN
VIR-5500 Phase 1 trial yields positive data in prostate cancer, Vir Biotechnology asserts - Traders Union
Vanguard Group Inc. Lowers Stock Position in Vir Biotechnology, Inc. $VIR - MarketBeat
HC Wainwright Brokers Boost Earnings Estimates for VIR - MarketBeat
Why Did Vir Biotechnology Stock Surge 60% After-Hours Today? - Stocktwits
Vir Biotechnology Names CEO Marianne De Backer as President - The Globe and Mail
According to the latest filing disclosed by the U.S. Securities and Exchange Commission (SEC), biotechnology company Vir Biotechnology, Inc. has announced a significant personnel appointment. - Bitget
Vir Biotechnology Appoints Marianne De Backer As President In Addition To CEO On March 4, 2026SEC Filing - TradingView
Vir Biotechnology appoints Marianne De Backer as president in addition to CEO on March 4, 2026SEC filing - marketscreener.com
Vir Biotechnology (NASDAQ:VIR) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
VIR: HC Wainwright & Co. Raises Price Target to $20, Maintains B - GuruFocus
Assessing Vir Biotechnology (VIR) Valuation After Astellas Alliance And VIR-5500 Phase 1 Update - simplywall.st
Vir Biotechnology, Inc. (VIR) Presents at 2026 ASCO Genitourinary Cancers SymposiumSlideshow - Seeking Alpha
VIR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Insider Sell: Vicki Sato Sells 22,000 Shares of Vir Biotechnology Inc (VIR) - GuruFocus
Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares - MarketBeat
22,000 Vir Biotechnology (VIR) shares sold under 10b5-1 plan - Stock Titan
VIR (NASDAQ: VIR) files Form 144 for 88,000 pre-IPO shares - Stock Titan
Vir Biotechnology closes $172.5 million public offering of common stock - Investing.com South Africa
Vir Biotechnology Raises Capital Through Public Stock Offering - TipRanks
Vir Biotechnology closes $172.5 million public offering of common stock By Investing.com - Investing.com UK
Vir Biotechnology completes $172.5M follow-on offering, issues 20.29M shares - TradingView
[8-K] Vir Biotechnology, Inc. Reports Material Event | VIR SEC FilingForm 8-K - Stock Titan
Vir Biotechnology Astellas Deal Puts VIR-5500 And Valuation In Focus - Yahoo Finance
Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Watch Vir Bio CEO on Cancer Treatment Progress, Potential Deals - Bloomberg
Why Vir Biotechnology (VIR) Is Up 20.2% After Astellas Deal And $150 Million Equity Raise - simplywall.st
Leerink Maintains Outperform on Vir Biotechnology, Inc. (VIR) Feb 2026 - Meyka
Insider Selling: Vir Biotechnology (NASDAQ:VIR) CFO Sells 1,634 Shares of Stock - MarketBeat
Brent Sabatini Sells 1,430 Shares of Vir Biotechnology (NASDAQ:VIR) Stock - MarketBeat
Mark Eisner Sells 1,616 Shares of Vir Biotechnology (NASDAQ:VIR) Stock - MarketBeat
Vir Biotechnology (NASDAQ:VIR) EVP Verneuil Vanina De Sells 3,117 Shares - MarketBeat
Vir Biotechnology Announces Significant Common Stock Offering - TipRanks
Vir Biotechnology prices $150M stock offering at $8.50/share By Investing.com - Investing.com Australia
Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 42,377 Shares - MarketBeat
Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 14,762 Shares - MarketBeat
Vir Biotechnology (NASDAQ: VIR) plans $141.1M stock sale - Stock Titan
Vir Biotechnology (VIR) to Sell 17.65M Shares; Astellas Collaboration Disclosed - Stock Titan
Vir Biotechnology (VIR) director Sato exercises options and sells 42,377 shares - Stock Titan
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity - Stock Titan
Vir Biotechnology (VIR) CFO executes automatic 10b5-1 share sale for taxes - Stock Titan
Vir Biotechnology (VIR) CMO reports 3,505-share Rule 10b5-1 stock sale - Stock Titan
Vir Biotechnology (VIR) EVP’s 10b5-1, tax-driven sales total 16,817 shares - Stock Titan
Vir Biotechnology to Participate in Upcoming Investor Conferences - Business Wire
Leerink raises Vir Biotechnology stock price target on partnership - Investing.com
Latham & Watkins Advises on Vir Biotechnology’s US$150 Million Public Offering of Common Stock - Latham & Watkins LLP
Vir Biotechnology (NASDAQ:VIR) Shares Gap DownShould You Sell? - MarketBeat
Vir Biotechnology (VIR) Earnings Call Transcript - AOL.com
Vir Biotechnology Prices $150 Mln Public Offering At $8.50 Per Share, Stock Down - Nasdaq
Vir Biotechnology stock tumbles on discounted share offering - Investing.com
Vir Biotechnology stock tumbles on discounted share offering By Investing.com - Investing.com India
Vir Biotechnology announces pricing of public offering of common stock at $8.50 per share - marketscreener.com
Vir Biotechnology (VIR) Prices Public Offering at $8.50 Per Shar - GuruFocus
Vir Biotechnology Announces Pricing of Public Offering of Common Stock - PharmiWeb.com
Vir Biotechnology launches $200M public stock offering - MSN
Vir Biotechnology Prices Public Offering at $8.50 per Share - Intellectia AI
Vir Biotechnology prices $150M stock offering at $8.50/share - Investing.com
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):